Injecting-related injury and disease among clients of a supervised injecting facility
MetadataShow full item record
Background: The process of drug injection may give rise to vascular and soft tissue injuries and infections. The social and physical environments in which drugs are injected play a significant role in these and other morbidities. Supervised injecting facilities (SIFs) seek to address such issues associated with public injecting drug use. Aims: Estimate lifetime prevalence of injecting-related problems, injury and disease and explore the socio-demographic and behavioral characteristics associated with the more serious complications. Design, Setting, Participants: Self-report data from 9552 injecting drug users (IDUs) registering to use the Sydney Medically Supervised Injecting Centre (MSIC). Findings: Lifetime history of either injecting-related problems (IRP) or injecting-related injury and disease (IRID) was reported by 29% of the 9552 IDUs; 26% (n = 2469) reported ever experiencing IRP and 10% (n = 972) reported IRID. Prevalence of IRP included difficulties finding a vein (18%), prominent scarring or bruising (14%) and swelling of hands or feet (7%). Prevalence of IRID included abscesses or skin infection (6%), thrombosis (4%), septicaemia (2%) and endocarditis (1%). Females, those who mainly injected drugs other than heroin, and those who reported a history of drug treatment, drug overdose, and/or sex work, were more likely to report lifetime IRID. Frequency and duration of injecting, recent public injecting, and sharing of needles and/or syringes were also independently associated with IRID. Conclusions: IRPs and IRIDs were common. Findings support the imperative for education and prevention activities to reduce the severity and burden of these preventable injecting outcomes. Through provision of hygienic environments and advice on venous access, safer injecting techniques and wound care, SIFs have the potential to address a number of risk factors for IRID. © 2009 Elsevier Ireland Ltd. All rights reserved.
Showing items related by title, author, creator and subject.
The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis)Sweeney, R.; Conroy, A.; Dwyer, Robyn; Aitken, C. (2009)Objective: We estimated the cost to the public health system of treating Injecting-Related Injuries and Diseases (IRIDs) in the three most populous states in Australia in the 12 months over 2005/06. Methods: We conducted ...
Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug usersDwyer, Robyn; Topp, L.; Maher, L.; Power, R.; Hellard, M.; Walsh, N.; Jauncey, M.; Conroy, A.; Lewis, J.; Aitken, C. (2009)Background: The prevalences and correlates of non-viral injecting-related injuries and diseases (IRIDs) in Australian injecting drug users (IDUs) remain unknown. Methods: A cross-sectional survey of IDUs was conducted in ...
Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapiesBetts, K.; Chan, G.; McIlwraith, F.; Dietze, P.; Whittaker, E.; Burns, L.; Alati, Rosa (2016)© 2016 Society for the Study of Addiction Aims: To test if polysubstance use profiles and drug-related outcomes differ between those receiving and not receiving opioid substitution therapies (OST) among people who inject ...